289 related articles for article (PubMed ID: 6705422)
1. Protein binding and drug clearance.
Rowland M
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():10-7. PubMed ID: 6705422
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics in clinical practice. I. Concepts.
Gibaldi M; Levy G
JAMA; 1976 Apr; 235(17):1864-7. PubMed ID: 946488
[TBL] [Abstract][Full Text] [Related]
3. Criticism of pharmacokinetic clearance concepts.
Keller F; Schoole J
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
[TBL] [Abstract][Full Text] [Related]
4. Altered hepatic blood flow and drug disposition.
Nies AS; Shand DG; Wilkinson GR
Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
[TBL] [Abstract][Full Text] [Related]
5. Commentary: a physiological approach to hepatic drug clearance.
Wilkinson GR; Shand DG
Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
[TBL] [Abstract][Full Text] [Related]
6. Presystemic extraction: mechanisms and consequences.
Greenblatt DJ
J Clin Pharmacol; 1993 Jul; 33(7):650-6. PubMed ID: 8366190
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics in renal disease.
Levy G
Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic parameters: which are necessary to define a drug substance?
Benet LZ
Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
[TBL] [Abstract][Full Text] [Related]
9. Principles of pharmacokinetics.
Tucker GT
Ciba Found Symp; 1979; (74):13-33. PubMed ID: 261681
[TBL] [Abstract][Full Text] [Related]
10. Biological determinants of altered pharmacokinetics in the elderly.
Shand DG
Gerontology; 1982; 28 Suppl 1():8-17. PubMed ID: 7044905
[TBL] [Abstract][Full Text] [Related]
11. [The use of the concepts of "half-life" and "clearance" in practice and in pharmacokinetics].
Raaflaub J
Schweiz Med Wochenschr; 1981 Sep; 111(38):1406-11. PubMed ID: 7280641
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic changes in critical illness.
Boucher BA; Wood GC; Swanson JM
Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
[TBL] [Abstract][Full Text] [Related]
13. Elimination half-life of drugs: value and limitations.
Greenblatt DJ
Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
[TBL] [Abstract][Full Text] [Related]
14. Dose adjustment in patients with liver disease.
Delcò F; Tchambaz L; Schlienger R; Drewe J; Krähenbühl S
Drug Saf; 2005; 28(6):529-45. PubMed ID: 15924505
[TBL] [Abstract][Full Text] [Related]
15. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
Morgan DJ; Bray KM
Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
[TBL] [Abstract][Full Text] [Related]
16. Hepatic elimination of drugs with concentration-dependent serum protein binding.
Huang JD; Oie S
J Pharmacokinet Biopharm; 1984 Feb; 12(1):67-81. PubMed ID: 6747819
[TBL] [Abstract][Full Text] [Related]
17. Clearance Concepts: Fundamentals and Application to Pharmacokinetic Behavior of Drugs.
Mehvar R
J Pharm Pharm Sci; 2018; 21(1s):88s-102s. PubMed ID: 30041730
[TBL] [Abstract][Full Text] [Related]
18. Determination of hepatic clearance with the account of drug-protein binding kinetics.
Berezhkovskiy LM
J Pharm Sci; 2012 Oct; 101(10):3936-45. PubMed ID: 22767378
[TBL] [Abstract][Full Text] [Related]
19. [Drug dosing in chronic hepatic disease (author's transl)].
Gugler R; Eichelbaum M
Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
Keller F; Maiga M; Neumayer HH; Lode H; Distler A
Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
